Global COVID-19 Saliva Screening Test Potential Market, By Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities and Colleges, Factories, Others), Technology (Fluorescence-Labeled Antigen/Antibodies Testing, RT-PCR, CRISPR-Cas9), Mode (Centralized Testing, Decentralized Testing), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global COVID-19 Saliva Screening Test Potential Market
Data Bridge Market Research analyses that the COVID-19 saliva screening test potential market will account for USD 4,138.40 million by 2028 and grow at a CAGR of 7.23% in the forecast period of 2021-2028.
COVID-19 saliva screening antigen/antibodies testing allows fast identification of people UN agency are actively contagious and is an efficient screening modality for cruise ships, airplanes, sports stadiums, and colleges. The mixture of vaccination and quick and frequent take-a-look acting victimization COVID-19 saliva screening antigen/antibodies test holds promising potential in ending the pandemic.
Timeline and scalability challenges about molecular swab-based SARS-CoV-2 testing are key factors that are prompting consumers to shift to saliva-based testing/screening approaches, thus lifting the market growth. The emergence of SARS-CoV-2 variants in South Africa, the U.K., and Brazil, which were observed to be more transmissible than the original strain, solidifies the need for rapid tests.
As the variety of individuals visiting public places increases and reaches pre-pandemic statistics during a few countries, there's a growing demand for speedy, point-of-care COVID-19 tests to mitigate infectious agent transmission from symptomless individuals.
This has increased the R&D for the event of straightforward nevertheless effective saliva-based tests and is predicted to make remunerative opportunities for many developers. However, the high penetration of swab-based testing methods and limitations related to the methodological approach will obstruct the growth of the market.
This COVID-19 saliva screening test potential market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on COVID-19 saliva screening test potential Market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global COVID-19 Saliva Screening Test Potential Market Scope and Market Size
The COVID-19 saliva screening test potential market is segmented on the basis of location, technology, and mode. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on location, the COVID-19 saliva screening test potential market is segmented into travel stations, sports arenas, entertainment venues, corporate campus environments, universities and colleges, factories and others.
- On the basis of technology, the COVID-19 saliva screening test potential market is segmented into fluorescence-labeled antigen/antibodies testing, RT-PCR and CRISPR-Cas9.
- On the basis of mode, the COVID-19 saliva screening test potential Market is segmented into centralized testing and decentralized testing.
COVID-19 Saliva Screening Test Potential Market Country Level Analysis
The COVID-19 saliva screening test potential market is segmented on the basis of location, technology, and mode.
The countries covered in the COVID-19 saliva screening test potential Market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the COVID-19 saliva screening test potential market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major players, high healthcare expenditure and rising use of technological advance devices in hospitals in this region. Europe on the other hand is projected to exhibit the highest growth rate during the forecast period due to the growing awareness about COVID-19 saliva screening test changing lifestyle, and increasing population in this region.
The country section of the COVID-19 saliva screening test potential market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The COVID-19 saliva screening test potential market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for COVID-19 saliva screening test potential market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the COVID-19 saliva screening test potential market. The data is available for historic period 2010 to 2019.
Competitive Landscape and COVID-19 Saliva Screening Test Potential Market Share Analysis
The COVID-19 saliva screening test potential market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to COVID-19 saliva screening test potential market.
The major players covered in the COVID-19 saliva screening test potential market report are ARUP Laboratories, Vatic Health, MOgene, Psomagen, Inc., DxTerity Diagnostics, Inc., Ambry Genetics, Fluidigm Corporation, Gravity Diagnostics, DNA Genotek, Inc., Quidel Corporation, Abbott, LumiraDX, FluroTech Ltd among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-